ACQUIREDT+30
Doogan Declan
Tenax Therapeutics Inc · NASDAQ
+53,000 sh · $101.8K
Filed 17 Sept 2026SEC Form 4view source
Renaissance Technologies
13F filer
$2.4M
152,600 sh
ADAR1 Capital Management, LLC
US insider
$1.6M
2,696,200 sh
Two Sigma Investments
13F filer
$1.1M
68,588 sh
Doogan Declan
US insider
$101.8K
53,000 sh
Staab Thomas R II
US insider
$11.0K
5,675 sh
Giordano Christopher Thomas
US insider
$8.8K
10,850 sh
BlackRock
13F filer
$904
300 sh
Doogan Declan
Tenax Therapeutics Inc · NASDAQ
+53,000 sh · $101.8K
Staab Thomas R II
Tenax Therapeutics Inc · NASDAQ
+5,675 sh · $11.0K
Giordano Christopher Thomas
Tenax Therapeutics Inc · NASDAQ
+6,000 sh · $11.3K
Giordano Christopher Thomas
Tenax Therapeutics Inc · NASDAQ
+4,850 sh · $8.8K
ADAR1 Capital Management, LLC
Tenax Therapeutics Inc · NASDAQ
+900,000 sh · $1.6M
ADAR1 Capital Management, LLC
Tenax Therapeutics Inc · NASDAQ
+187,704 sh · $337.6K
ADAR1 Capital Management, LLC
Tenax Therapeutics Inc · NASDAQ
+403,571 sh · $722.6K
ADAR1 Capital Management, LLC
Tenax Therapeutics Inc · NASDAQ
+179,058 sh · $321.6K
ADAR1 Capital Management, LLC
Tenax Therapeutics Inc · NASDAQ
+202,124 sh · $359.5K
ADAR1 Capital Management, LLC
Tenax Therapeutics Inc · NASDAQ
+107,374 sh · $188.4K